Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
"MTV273" - Google News
Get the latest updates from "MTV273" - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated over 2 years ago
Lather, Rinse, Repeat: Will It Work With BCMA-Targeted Therapies For Multiple Myeloma? - The Myeloma Beacon
over 4 years ago
Lather, Rinse, Repeat: Will It Work With BCMA-Targeted Therapies For Multiple Myeloma...
Abbvie comes to the multiple myeloma party late - Vantage
about 5 years ago
Abbvie comes to the multiple myeloma party late Vantage
Abbvie comes to the multiple myeloma party late - Vantage
about 5 years ago
Abbvie comes to the multiple myeloma party late VantageIn piling on to...
Sanofi does a spring clean - Vantage
about 5 years ago
Sanofi does a spring clean VantageBuried deep in today's fourth-quarter financials report...
Sanofi does a spring clean | Evaluate - Vantage
about 5 years ago
Sanofi does a spring clean | Evaluate Vantage
Novartis and Gilead’s multiple myeloma CARs diverge - Vantage
about 5 years ago
Novartis and Gilead’s multiple myeloma CARs diverge VantageCompetition in the BCMA-targeting space...
Novartis and Gilead's multiple myeloma CARs diverge - Vantage
about 5 years ago
Novartis and Gilead's multiple myeloma CARs diverge Vantage
The first real challenge to multiple myeloma CAR-T therapy - Vantage
over 5 years ago
The first real challenge to multiple myeloma CAR-T therapy VantageAmgen's AMG 420...
The first real challenge to multiple myeloma CAR-T therapy - Vantage
over 5 years ago
The first real challenge to multiple myeloma CAR-T therapy Vantage
Form 6-K NOVARTIS AG For: Jun 30 - StreetInsider.com
almost 6 years ago
Form 6-K NOVARTIS AG For: Jun 30 StreetInsider.comTGT 2. SPY 3. URBN...